Dorothea Siegel-Axel
Corporate Officer/Principal presso Eberhard Karls Universität Tübingen
Profilo
Dorothea Siegel-Axel is the founder of Corimmun GmbH founded in 2006 and advanceCOR GmbH founded in 2012.
She is currently the Head-Cardiology Department at Eberhard Karls Universität Tübingen.
Posizioni attive di Dorothea Siegel-Axel
| Società | Posizione | Inizio |
|---|---|---|
| Eberhard Karls Universität Tübingen | Corporate Officer/Principal | - |
Precedenti posizioni note di Dorothea Siegel-Axel
| Società | Posizione | Fine |
|---|---|---|
advanceCOR GmbH
 advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Fondatore | - |
Corimmun GmbH
 Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Corimmun GmbH
Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Health Technology |
advanceCOR GmbH
advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Health Technology |
- Borsa valori
- Insiders
- Dorothea Siegel-Axel
